Skip to content

Comparison of the results and complication of the two methods Chlorhexidine–Alcohol and Povidone–Iodine in non-emergency abdominal surgery

Clinical trials of surgical site with disinfectant spray Chlorhexidine-Alcohol compared to those who received Povidone-Iodine to reduce the amount of infection in surgery.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015110724706N1
Enrollment
200
Registered
2016-05-02
Start date
2015-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection abdominal postoperative. Foreign body accidentally left in body cavity or operation wound following a procedure

Interventions

Intervention 1: Intervention 2: Povidone–Iodine (Betadin), 10 milliliters once before surgery, Povidone–Iodine is a stable chemical complex of Polyvinylpyrrolidone (Povidone, PVP) and elemental iodine
Prevention
Intervention 2: Povidone–Iodine (Betadin), 10 milliliters once before surgery, Povidone–Iodine is a stable chemical complex of Polyvinylpyrrolidone (Povidone, PVP) and elemental iodine. It contains fr
Intervention 1: Spray disinfectant Chlorhexidine-alcohol, 10 milliliters once before surgery, Chlorhexidine-Alcohol based chlorhexidine Gluconate and 70% isopropyl alcohol 2% D is formulated. How to u

Sponsors

Vice chancellor for research, Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Hospital patients undergoing elective abdominal surgery (clean-contaminated) were put into the project. Exclusion criteria: All patients who do not follow. Patients who died during this study; Clear immunocompromised patients (transplant patients and AIDS), chronic skin disease; radiation therapy and chronic inflammatory disease; All patients who do not follow; Patients who died during this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Infection. Timepoint: One and two weeks after operation. Method of measurement: Medical evaluation.

Secondary

MeasureTime frame
The number of bacteria grown. Timepoint: One and two weeks after operation. Method of measurement: Laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ebrahimi

Baqiyatallah University of Medical Sciences

ae_49341@yahoo.com+98 21 8805 3766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026